Sumitomo Pharma Co., Ltd.

4506・Prime Market・Pharmaceuticals

Official website

Sumitomo Pharma Co., Ltd.

4506・Prime Market・Pharmaceuticals

Official website

Sumitomo Pharma Co., Ltd.4506

Reference Indicators

Market Cap

5,189¥100M

P/E (Forecast)

7.5x

P/B

1.8x

Dividend Yield (Forecast)

—

ROE

36.5%

EV/EBITDA

5.1x

Financial Summary

Unit: ¥M

Item	2022Mar 2022	2023Mar 2023	2024Mar 2024	2025Mar 2025	2026Mar 2026
Net Sales	560,035	555,544	314,558	398,832	453,294
Cost of Sales	157,127	178,919	126,577	153,437	196,401
Gross Profit	402,908	376,625	187,981	245,395	256,893
SG&A Expenses	249,081	373,316	429,538	180,605	162,557
Operating Income	60,234	-76,979	-354,859	28,804	107,338
Pre-tax Income	82,961	-47,920	-323,114	17,611	100,344
Income Taxes	42,361	48,794	-8,185	-6,024	-6,521
Net Income	56,413	-74,512	-314,969	23,634	106,865
EBITDA	98,582	-35,716	-317,094	54,366	128,124
Gross Margin	71.9%	67.8%	59.8%	61.5%	56.7%
Operating Margin	10.8%	-13.9%	-112.8%	7.2%	23.7%
ROA	4.3%	-6.6%	-34.7%	3.2%	13.3%
ROE	9.3%	-18.3%	-201.8%	13.9%	36.5%

Segment Performance

Unit: ¥M

2026

Segment	Net Sales	Operating Income	Operating Margin
日本	92,365	12,352	13.4%
北米	337,923	75,742	22.4%
アジア	23,006	9,452	41.1%